G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Estimates vary regarding the number of G protein-coupled receptors (GPCRs), the largest family of membrane receptors that are targeted by approved drugs, and the number of such drugs that target GPCRs. We review current knowledge regarding GPCRs as drug targets by integrating data from public databa...
Uložené v:
| Vydané v: | Molecular pharmacology Ročník 93; číslo 4; s. 251 |
|---|---|
| Hlavní autori: | , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
01.04.2018
|
| Predmet: | |
| ISSN: | 1521-0111, 1521-0111 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Estimates vary regarding the number of G protein-coupled receptors (GPCRs), the largest family of membrane receptors that are targeted by approved drugs, and the number of such drugs that target GPCRs. We review current knowledge regarding GPCRs as drug targets by integrating data from public databases (ChEMBL, Guide to PHARMACOLOGY, and DrugBank) and from the Broad Institute Drug Repurposing Hub. To account for discrepancies among these sources, we curated a list of GPCRs currently targeted by approved drugs. As of November 2017, 134 GPCRs are targets for drugs approved in the United States or European Union; 128 GPCRs are targets for drugs listed in the Food and Drug Administration Orange Book. We estimate that ∼700 approved drugs target GPCRs, implying that approximately 35% of approved drugs target GPCRs. GPCRs and GPCR-related proteins, i.e., those upstream of or downstream from GPCRs, represent ∼17% of all protein targets for approved drugs, with GPCRs themselves accounting for ∼12%. As such, GPCRs constitute the largest family of proteins targeted by approved drugs. Drugs that currently target GPCRs and GPCR-related proteins are primarily small molecules and peptides. Since ∼100 of the ∼360 human endo-GPCRs (other than olfactory, taste, and visual GPCRs) are orphan receptors (lacking known physiologic agonists), the number of GPCR targets, the number of GPCR-targeted drugs, and perhaps the types of drugs will likely increase, thus further expanding this GPCR repertoire and the many roles of GPCR drugs in therapeutics. |
|---|---|
| AbstractList | Estimates vary regarding the number of G protein-coupled receptors (GPCRs), the largest family of membrane receptors that are targeted by approved drugs, and the number of such drugs that target GPCRs. We review current knowledge regarding GPCRs as drug targets by integrating data from public databases (ChEMBL, Guide to PHARMACOLOGY, and DrugBank) and from the Broad Institute Drug Repurposing Hub. To account for discrepancies among these sources, we curated a list of GPCRs currently targeted by approved drugs. As of November 2017, 134 GPCRs are targets for drugs approved in the United States or European Union; 128 GPCRs are targets for drugs listed in the Food and Drug Administration Orange Book. We estimate that ∼700 approved drugs target GPCRs, implying that approximately 35% of approved drugs target GPCRs. GPCRs and GPCR-related proteins, i.e., those upstream of or downstream from GPCRs, represent ∼17% of all protein targets for approved drugs, with GPCRs themselves accounting for ∼12%. As such, GPCRs constitute the largest family of proteins targeted by approved drugs. Drugs that currently target GPCRs and GPCR-related proteins are primarily small molecules and peptides. Since ∼100 of the ∼360 human endo-GPCRs (other than olfactory, taste, and visual GPCRs) are orphan receptors (lacking known physiologic agonists), the number of GPCR targets, the number of GPCR-targeted drugs, and perhaps the types of drugs will likely increase, thus further expanding this GPCR repertoire and the many roles of GPCR drugs in therapeutics.Estimates vary regarding the number of G protein-coupled receptors (GPCRs), the largest family of membrane receptors that are targeted by approved drugs, and the number of such drugs that target GPCRs. We review current knowledge regarding GPCRs as drug targets by integrating data from public databases (ChEMBL, Guide to PHARMACOLOGY, and DrugBank) and from the Broad Institute Drug Repurposing Hub. To account for discrepancies among these sources, we curated a list of GPCRs currently targeted by approved drugs. As of November 2017, 134 GPCRs are targets for drugs approved in the United States or European Union; 128 GPCRs are targets for drugs listed in the Food and Drug Administration Orange Book. We estimate that ∼700 approved drugs target GPCRs, implying that approximately 35% of approved drugs target GPCRs. GPCRs and GPCR-related proteins, i.e., those upstream of or downstream from GPCRs, represent ∼17% of all protein targets for approved drugs, with GPCRs themselves accounting for ∼12%. As such, GPCRs constitute the largest family of proteins targeted by approved drugs. Drugs that currently target GPCRs and GPCR-related proteins are primarily small molecules and peptides. Since ∼100 of the ∼360 human endo-GPCRs (other than olfactory, taste, and visual GPCRs) are orphan receptors (lacking known physiologic agonists), the number of GPCR targets, the number of GPCR-targeted drugs, and perhaps the types of drugs will likely increase, thus further expanding this GPCR repertoire and the many roles of GPCR drugs in therapeutics. Estimates vary regarding the number of G protein-coupled receptors (GPCRs), the largest family of membrane receptors that are targeted by approved drugs, and the number of such drugs that target GPCRs. We review current knowledge regarding GPCRs as drug targets by integrating data from public databases (ChEMBL, Guide to PHARMACOLOGY, and DrugBank) and from the Broad Institute Drug Repurposing Hub. To account for discrepancies among these sources, we curated a list of GPCRs currently targeted by approved drugs. As of November 2017, 134 GPCRs are targets for drugs approved in the United States or European Union; 128 GPCRs are targets for drugs listed in the Food and Drug Administration Orange Book. We estimate that ∼700 approved drugs target GPCRs, implying that approximately 35% of approved drugs target GPCRs. GPCRs and GPCR-related proteins, i.e., those upstream of or downstream from GPCRs, represent ∼17% of all protein targets for approved drugs, with GPCRs themselves accounting for ∼12%. As such, GPCRs constitute the largest family of proteins targeted by approved drugs. Drugs that currently target GPCRs and GPCR-related proteins are primarily small molecules and peptides. Since ∼100 of the ∼360 human endo-GPCRs (other than olfactory, taste, and visual GPCRs) are orphan receptors (lacking known physiologic agonists), the number of GPCR targets, the number of GPCR-targeted drugs, and perhaps the types of drugs will likely increase, thus further expanding this GPCR repertoire and the many roles of GPCR drugs in therapeutics. |
| Author | Insel, Paul A Sriram, Krishna |
| Author_xml | – sequence: 1 givenname: Krishna surname: Sriram fullname: Sriram, Krishna organization: Departments of Pharmacology (K.S., P.A.I.) and Medicine (P.A.I.), University of California San Diego, La Jolla, California – sequence: 2 givenname: Paul A surname: Insel fullname: Insel, Paul A email: pinsel@ucsd.edu organization: Departments of Pharmacology (K.S., P.A.I.) and Medicine (P.A.I.), University of California San Diego, La Jolla, California pinsel@ucsd.edu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29298813$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkMtLxDAQxoOsuA-9epQcvVTzapt4kaXqrrCiyHouaTNdVtqmJq2y_71B18dh-L4ZfvMxzBSNWtsCQqeUXFDKxGVj62DSUJQk7ABNaMxoREI7-ufHaOr9KyFUxJIcoTFTTElJ-QTlC_zkbA_bNsrs0NVg8DOU0PXWeaw9Xmu3gd7jyjo87zpn3wNx44aNv8JL-4EfdLv7hXRr_oZf0PUxOqx07eFkrzP0cne7zpbR6nFxn81XUSm46qOCpZpwboyAlFUqJqI0JWFJygWPmSmYkRIKxSGOqVAy1QWvVBULLsuCBZDN0Pl3bjjxbQDf583Wl1DXugU7-JwqKdKwmyQBPdujQ9GAyTu3bbTb5T9PYZ9oIGQH |
| CitedBy_id | crossref_primary_10_1016_j_tips_2019_12_008 crossref_primary_10_3390_cells10082059 crossref_primary_10_1016_j_pharmthera_2022_108331 crossref_primary_10_1186_s12915_023_01723_x crossref_primary_10_1210_endocr_bqac054 crossref_primary_10_3390_ph14050439 crossref_primary_10_1038_s41598_022_21063_0 crossref_primary_10_1134_S0022093023070013 crossref_primary_10_1016_j_tips_2019_04_001 crossref_primary_10_3390_brainsci15091004 crossref_primary_10_3390_ijms20030559 crossref_primary_10_1016_j_jmb_2022_167620 crossref_primary_10_3389_fendo_2024_1404969 crossref_primary_10_1016_j_mce_2019_01_021 crossref_primary_10_1038_s41467_022_35716_1 crossref_primary_10_3390_cancers14092255 crossref_primary_10_3390_antib12020030 crossref_primary_10_1016_j_neuropharm_2025_110496 crossref_primary_10_1016_j_pharmthera_2022_108217 crossref_primary_10_1016_j_tem_2022_12_001 crossref_primary_10_1038_s41467_022_35739_8 crossref_primary_10_1134_S0006297923140110 crossref_primary_10_3390_biom12101407 crossref_primary_10_1016_j_jbc_2021_101369 crossref_primary_10_1016_j_metabol_2020_154394 crossref_primary_10_1016_j_sbi_2021_03_013 crossref_primary_10_1016_j_jbc_2023_105293 crossref_primary_10_3389_fphar_2019_00112 crossref_primary_10_1016_j_ijbiomac_2025_146141 crossref_primary_10_1016_j_pharmthera_2021_108044 crossref_primary_10_1007_s10822_020_00339_5 crossref_primary_10_1096_fba_2024_00180 crossref_primary_10_1002_prp2_1013 crossref_primary_10_1111_bcpt_13923 crossref_primary_10_1186_s12902_024_01798_9 crossref_primary_10_1042_BST20201144 crossref_primary_10_1371_journal_pbio_3000434 crossref_primary_10_1016_j_coemr_2020_11_008 crossref_primary_10_1111_bph_16076 crossref_primary_10_1016_j_cois_2018_08_010 crossref_primary_10_1038_s41467_022_28152_8 crossref_primary_10_1186_s12964_020_00537_6 crossref_primary_10_3390_biom14080923 crossref_primary_10_1038_s41598_018_26113_0 crossref_primary_10_3390_cancers14205142 crossref_primary_10_1007_s12035_024_04293_3 crossref_primary_10_3390_molecules23030690 crossref_primary_10_1038_s41380_021_01040_1 crossref_primary_10_1097_j_pain_0000000000003120 crossref_primary_10_1038_s41467_023_42082_z crossref_primary_10_7554_eLife_75419 crossref_primary_10_1021_acs_biochem_4c00676 crossref_primary_10_1016_j_drudis_2020_08_006 crossref_primary_10_1038_s41467_022_31357_6 crossref_primary_10_1016_j_biopha_2025_118523 crossref_primary_10_3390_molecules28196925 crossref_primary_10_1146_annurev_pharmtox_090324_021727 crossref_primary_10_3389_fimmu_2020_550824 crossref_primary_10_1186_s12964_024_01802_8 crossref_primary_10_1073_pnas_2000430117 crossref_primary_10_1172_JCI182325 crossref_primary_10_2174_1573399819666221102113217 crossref_primary_10_1016_j_jmgm_2023_108488 crossref_primary_10_1016_j_molmed_2020_08_011 crossref_primary_10_4155_fmc_2019_0357 crossref_primary_10_7717_peerj_17631 crossref_primary_10_3390_pharmaceutics14010161 crossref_primary_10_1016_j_bpj_2023_03_007 crossref_primary_10_1039_D0RA08003A crossref_primary_10_26508_lsa_202402657 crossref_primary_10_3390_ijms20246226 crossref_primary_10_1002_anie_201813110 crossref_primary_10_1038_s41557_025_01789_w crossref_primary_10_1093_eurheartj_ehac094 crossref_primary_10_1016_j_jbc_2024_105668 crossref_primary_10_1152_ajprenal_00056_2025 crossref_primary_10_3389_fcell_2021_636778 crossref_primary_10_1007_s00232_024_00333_0 crossref_primary_10_3390_ijms25136876 crossref_primary_10_1016_j_bbamem_2020_183354 crossref_primary_10_1016_j_neuropharm_2024_110092 crossref_primary_10_1016_j_pharmthera_2022_108242 crossref_primary_10_1042_BST20180140 crossref_primary_10_1016_j_actbio_2021_06_012 crossref_primary_10_1038_s41586_020_2888_2 crossref_primary_10_1038_s41598_024_75240_4 crossref_primary_10_1016_j_molmet_2023_101866 crossref_primary_10_1042_BST20201001 crossref_primary_10_1016_j_str_2022_04_012 crossref_primary_10_1016_j_bcp_2023_116013 crossref_primary_10_1097_FJC_0000000000001318 crossref_primary_10_3390_ijms20246218 crossref_primary_10_1007_s43440_022_00371_2 crossref_primary_10_1038_s41598_021_87251_6 crossref_primary_10_1007_s12551_021_00878_7 crossref_primary_10_1080_21655979_2021_1971035 crossref_primary_10_1074_jbc_RA119_011461 crossref_primary_10_1515_hsz_2021_0128 crossref_primary_10_3389_fphar_2023_1126119 crossref_primary_10_3390_ijms22168647 crossref_primary_10_1134_S0006297924050158 crossref_primary_10_1016_j_tibtech_2024_06_003 crossref_primary_10_1016_S2095_3119_19_62860_1 crossref_primary_10_1021_acs_jcim_5c01163 crossref_primary_10_3390_ijms23021000 crossref_primary_10_1134_S000629792405002X crossref_primary_10_3389_fendo_2022_880002 crossref_primary_10_3390_cancers12082232 crossref_primary_10_3389_fcell_2024_1326231 crossref_primary_10_3389_fimmu_2021_702785 crossref_primary_10_1007_s12268_019_1030_1 crossref_primary_10_1021_acs_biochem_4c00779 crossref_primary_10_3390_ijms222212329 crossref_primary_10_1042_BST20201110 crossref_primary_10_1038_s41598_024_65445_y crossref_primary_10_1039_D4MD00262H crossref_primary_10_1073_pnas_1819778116 crossref_primary_10_1038_s41467_024_55381_w crossref_primary_10_1021_jacs_1c03696 crossref_primary_10_1016_j_saa_2022_122303 crossref_primary_10_3390_molecules28176375 crossref_primary_10_1007_s11704_021_0478_6 crossref_primary_10_1038_s41598_022_24885_0 crossref_primary_10_1016_j_genrep_2020_100882 crossref_primary_10_1016_j_jbc_2023_105370 crossref_primary_10_1042_BST20190149 crossref_primary_10_3389_fimmu_2022_1084394 crossref_primary_10_3390_life13040940 crossref_primary_10_1038_s41467_021_27540_w crossref_primary_10_1038_s41467_022_33569_2 crossref_primary_10_1016_j_bpj_2024_12_018 crossref_primary_10_1111_dme_14978 crossref_primary_10_1002_ctm2_1124 crossref_primary_10_1111_dme_14974 crossref_primary_10_1016_j_sajb_2024_04_047 crossref_primary_10_3390_ijms222413387 crossref_primary_10_7554_eLife_85131 crossref_primary_10_1016_j_molcel_2023_06_006 crossref_primary_10_1038_s42003_024_06906_y crossref_primary_10_1016_j_bbamem_2020_183547 crossref_primary_10_1186_s12859_022_04877_7 crossref_primary_10_7554_eLife_96513_4 crossref_primary_10_3390_ijms26010202 crossref_primary_10_1016_j_molmet_2025_102097 crossref_primary_10_3390_molecules26185618 crossref_primary_10_1007_s00232_024_00324_1 crossref_primary_10_1038_s41467_023_37808_y crossref_primary_10_1016_j_biopsych_2021_05_026 crossref_primary_10_1016_j_ijbiomac_2025_147665 crossref_primary_10_1016_j_chemphyslip_2021_105120 crossref_primary_10_3389_fendo_2020_556610 crossref_primary_10_1016_j_tips_2022_12_002 crossref_primary_10_1073_pnas_2106041118 crossref_primary_10_3390_ijms25063089 crossref_primary_10_1186_s12931_024_02680_x crossref_primary_10_2217_pgs_2018_0199 crossref_primary_10_3390_ijms23158516 crossref_primary_10_1016_j_neuroscience_2024_08_032 crossref_primary_10_7554_eLife_49416 crossref_primary_10_3390_life12091393 crossref_primary_10_3390_ijms25168984 crossref_primary_10_1038_s41598_021_88939_5 crossref_primary_10_1016_j_heliyon_2024_e24577 crossref_primary_10_3389_fphy_2022_963716 crossref_primary_10_1124_molpharm_121_000302 crossref_primary_10_1016_j_cell_2022_02_011 crossref_primary_10_1021_jacs_1c02586 crossref_primary_10_1111_bph_14953 crossref_primary_10_3390_ijms22041662 crossref_primary_10_1016_j_molmet_2022_101474 crossref_primary_10_1016_j_pharmthera_2020_107704 crossref_primary_10_1007_s00018_023_04765_0 crossref_primary_10_1016_j_cbpc_2022_109297 crossref_primary_10_1016_j_intimp_2021_107872 crossref_primary_10_1016_j_canlet_2023_216191 crossref_primary_10_1016_j_bios_2019_04_041 crossref_primary_10_3748_wjg_v27_i8_677 crossref_primary_10_1016_j_bpj_2019_08_034 crossref_primary_10_1016_j_str_2021_01_004 crossref_primary_10_1210_endocr_bqab134 crossref_primary_10_1007_s40291_022_00592_4 crossref_primary_10_3390_app10207100 crossref_primary_10_1128_spectrum_00150_22 crossref_primary_10_1016_j_ejphar_2023_176123 crossref_primary_10_1124_pharmrev_120_000082 crossref_primary_10_3390_ph15111304 crossref_primary_10_1016_j_molpha_2025_100059 crossref_primary_10_3389_fcell_2021_815291 crossref_primary_10_1124_mol_119_118869 crossref_primary_10_1074_jbc_REV119_007060 crossref_primary_10_3389_fphar_2019_00176 crossref_primary_10_1111_tra_12619 crossref_primary_10_1016_j_bbamcr_2020_118718 crossref_primary_10_1016_j_jep_2025_119679 crossref_primary_10_3390_cells11071097 crossref_primary_10_1016_j_jtbi_2018_02_014 crossref_primary_10_3390_membranes13030301 crossref_primary_10_1063_5_0097853 crossref_primary_10_1111_bph_15028 crossref_primary_10_2337_db23_0095 crossref_primary_10_1186_s12964_020_00620_y crossref_primary_10_1016_j_tips_2022_09_009 crossref_primary_10_3390_ijms222111546 crossref_primary_10_1007_s00418_021_02032_6 crossref_primary_10_31083_j_fbl2910355 crossref_primary_10_3390_membranes11060451 crossref_primary_10_3389_fmolb_2022_832379 crossref_primary_10_1073_pnas_2407744121 crossref_primary_10_1002_adbi_202200151 crossref_primary_10_3389_fendo_2022_934685 crossref_primary_10_1016_j_jbc_2024_107211 crossref_primary_10_1016_j_coph_2020_04_002 crossref_primary_10_3389_fphys_2023_1310197 crossref_primary_10_1002_prot_25777 crossref_primary_10_1080_07391102_2024_2330714 crossref_primary_10_1007_s12268_023_1895_x crossref_primary_10_1074_jbc_AC120_014770 crossref_primary_10_1016_j_cellsig_2020_109649 crossref_primary_10_1177_17539447231199350 crossref_primary_10_1002_cbic_202400397 crossref_primary_10_1016_j_bbamcr_2022_119235 crossref_primary_10_1371_journal_pone_0270965 crossref_primary_10_1074_jbc_RA118_006231 crossref_primary_10_1124_pharmrev_123_001015 crossref_primary_10_1016_j_biopha_2022_112770 crossref_primary_10_1038_s41467_024_52947_6 crossref_primary_10_1111_age_13476 crossref_primary_10_1007_s10822_022_00454_5 crossref_primary_10_3390_ijms242216182 crossref_primary_10_1016_j_pep_2020_105617 crossref_primary_10_1021_acsptsci_4c00129 crossref_primary_10_3389_fphar_2018_00431 crossref_primary_10_1210_endocr_bqae052 crossref_primary_10_1126_science_aau2078 crossref_primary_10_3390_biom11101503 crossref_primary_10_1093_jb_mvad110 crossref_primary_10_1016_j_cell_2020_06_020 crossref_primary_10_1097_FJC_0000000000001265 crossref_primary_10_3389_fimmu_2023_1254446 crossref_primary_10_1016_j_jmb_2022_167927 crossref_primary_10_1038_s41467_024_49000_x crossref_primary_10_1186_s13578_023_01035_1 crossref_primary_10_1096_fj_202302298R crossref_primary_10_1111_febs_17049 crossref_primary_10_1172_JCI160617 crossref_primary_10_1002_prot_26762 crossref_primary_10_3390_ph14020087 crossref_primary_10_3390_biomedicines6020065 crossref_primary_10_1038_s12276_021_00678_9 crossref_primary_10_1007_s12035_025_04893_7 crossref_primary_10_1016_j_chempr_2024_02_022 crossref_primary_10_1016_j_drudis_2019_09_003 crossref_primary_10_1016_j_mce_2024_112192 crossref_primary_10_3389_fphar_2019_00531 crossref_primary_10_1007_s11010_024_05134_6 crossref_primary_10_1016_j_bpc_2024_107289 crossref_primary_10_1016_j_tips_2020_10_001 crossref_primary_10_1016_j_dci_2023_105126 crossref_primary_10_1111_bph_17461 crossref_primary_10_1186_s13578_020_00474_4 crossref_primary_10_1002_bies_202300053 crossref_primary_10_1016_j_ejphar_2024_176587 crossref_primary_10_1073_pnas_2208541120 crossref_primary_10_1111_bph_16495 crossref_primary_10_1016_j_jmb_2023_167950 crossref_primary_10_3390_ijms25105474 crossref_primary_10_1016_j_ymeth_2021_10_009 crossref_primary_10_7554_eLife_104725_3 crossref_primary_10_1007_s12268_018_0975_9 crossref_primary_10_1089_adt_2018_868 crossref_primary_10_1210_endrev_bnac033 crossref_primary_10_1016_j_chemphyslip_2019_02_010 crossref_primary_10_1111_bph_16008 crossref_primary_10_1002_ange_201813110 crossref_primary_10_1016_j_phrs_2022_106346 crossref_primary_10_3390_ijms26062501 crossref_primary_10_1016_j_bpj_2022_07_034 crossref_primary_10_3389_fchem_2021_671483 crossref_primary_10_1158_1541_7786_MCR_19_1120 crossref_primary_10_3389_fphar_2021_669227 crossref_primary_10_1038_s41598_021_91934_5 crossref_primary_10_1017_S1431927622004822 crossref_primary_10_1080_17460441_2025_2515045 crossref_primary_10_3389_fphar_2024_1394516 crossref_primary_10_1016_j_tips_2022_08_003 crossref_primary_10_1186_s12958_024_01324_5 crossref_primary_10_1111_bph_15074 crossref_primary_10_3390_polym14102021 crossref_primary_10_3390_genes11060694 crossref_primary_10_1002_jsp2_1111 crossref_primary_10_1016_j_abb_2021_108794 crossref_primary_10_1007_s10822_024_00551_7 crossref_primary_10_1016_j_bbagen_2025_130758 crossref_primary_10_1016_j_heliyon_2024_e37915 crossref_primary_10_3390_ijms20092175 crossref_primary_10_1016_j_intimp_2022_108743 crossref_primary_10_3390_info13050262 crossref_primary_10_1039_D3RA07380G crossref_primary_10_1080_07391102_2021_1873187 crossref_primary_10_1038_s41589_025_01928_x crossref_primary_10_1002_bkcs_12427 crossref_primary_10_1002_chem_202500379 crossref_primary_10_3390_cancers15071982 crossref_primary_10_1038_s41401_024_01413_6 crossref_primary_10_1016_j_biopha_2025_117966 crossref_primary_10_3389_fendo_2021_706957 crossref_primary_10_1016_j_tibs_2021_05_002 crossref_primary_10_1038_s41386_021_00962_2 crossref_primary_10_7554_eLife_104725 crossref_primary_10_3389_fmolb_2024_1158852 crossref_primary_10_1073_pnas_2404754122 crossref_primary_10_1002_cmdc_202200413 crossref_primary_10_1016_j_drudis_2019_02_010 crossref_primary_10_1038_s41531_024_00788_x crossref_primary_10_1007_s10822_022_00456_3 crossref_primary_10_3389_fphys_2021_710968 crossref_primary_10_1126_sciadv_adu1670 crossref_primary_10_1016_j_str_2020_01_001 crossref_primary_10_1146_annurev_biochem_081424_044501 crossref_primary_10_1146_annurev_pharmtox_030220_121042 crossref_primary_10_1186_s13321_024_00806_3 crossref_primary_10_3390_ijms26072849 crossref_primary_10_1155_2024_2005589 crossref_primary_10_1111_bph_15095 crossref_primary_10_1016_j_jbc_2024_107481 crossref_primary_10_1007_s00210_023_02465_x crossref_primary_10_1016_j_ejphar_2021_174203 crossref_primary_10_3389_fimmu_2025_1538384 crossref_primary_10_3390_ijerph191912361 crossref_primary_10_3390_ijms21249629 crossref_primary_10_1038_s42003_021_02188_w crossref_primary_10_1016_j_molmed_2022_08_011 crossref_primary_10_3389_fbioe_2021_694100 crossref_primary_10_3390_ijms23094556 crossref_primary_10_1111_bph_16057 crossref_primary_10_1038_s41467_025_59418_6 crossref_primary_10_3389_fcvm_2022_1011176 crossref_primary_10_1002_aic_16398 crossref_primary_10_3390_ijms20061437 crossref_primary_10_1515_med_2022_0498 crossref_primary_10_1109_ACCESS_2021_3086051 crossref_primary_10_1111_eci_70092 crossref_primary_10_1016_j_bcp_2023_115919 crossref_primary_10_1021_acs_jcim_5c00489 crossref_primary_10_3389_fphys_2024_1401768 crossref_primary_10_1016_j_biopha_2024_116471 crossref_primary_10_1002_prp2_913 crossref_primary_10_1124_mol_119_117267 crossref_primary_10_1002_mas_21637 crossref_primary_10_1097_FJC_0000000000001236 crossref_primary_10_1080_17460441_2024_2329104 crossref_primary_10_1038_s41392_023_01427_2 crossref_primary_10_1016_j_csbj_2022_01_015 crossref_primary_10_3389_fmicb_2021_638869 crossref_primary_10_1007_s10072_025_08260_1 crossref_primary_10_1038_s42004_025_01504_3 crossref_primary_10_1371_journal_pone_0254118 crossref_primary_10_1038_s41467_020_14526_3 crossref_primary_10_1016_j_compbiomed_2023_106988 crossref_primary_10_3390_life12111687 crossref_primary_10_1016_j_drudis_2024_103922 crossref_primary_10_3390_molecules25204724 crossref_primary_10_1016_j_bbagen_2021_129969 crossref_primary_10_1016_j_bcp_2023_115800 crossref_primary_10_1016_j_ejphar_2019_01_026 crossref_primary_10_1016_j_jbc_2022_102421 crossref_primary_10_1002_anie_202215547 crossref_primary_10_1007_s12016_020_08829_y crossref_primary_10_1038_s41467_022_29231_6 crossref_primary_10_1051_jbio_2021011 crossref_primary_10_1093_cvr_cvac171 crossref_primary_10_3389_fimmu_2024_1490593 crossref_primary_10_1016_j_cell_2024_01_028 crossref_primary_10_1177_1010428320962588 crossref_primary_10_1016_j_xpro_2024_103355 crossref_primary_10_1016_j_ejphar_2023_175719 crossref_primary_10_3390_ijms25010291 crossref_primary_10_1016_j_aaf_2023_05_009 crossref_primary_10_1111_febs_15729 crossref_primary_10_3390_ijms21249728 crossref_primary_10_3390_molecules28104211 crossref_primary_10_1016_j_neuropharm_2021_108611 crossref_primary_10_1111_febs_15841 crossref_primary_10_1111_jdi_14317 crossref_primary_10_3389_fimmu_2023_1111960 crossref_primary_10_3389_fphar_2022_893422 crossref_primary_10_3390_ijms19071886 crossref_primary_10_3390_jpm11010020 crossref_primary_10_1073_pnas_2302823120 crossref_primary_10_3389_fchem_2020_00571 crossref_primary_10_1038_s41573_024_01083_3 crossref_primary_10_1093_jnci_djy127 crossref_primary_10_3390_cells12202460 crossref_primary_10_1038_s41467_019_09938_9 crossref_primary_10_3389_fphar_2022_1049640 crossref_primary_10_3389_fphar_2024_1455231 crossref_primary_10_1002_ange_202215547 crossref_primary_10_1021_acsomega_5c02173 crossref_primary_10_3390_ijms24076136 crossref_primary_10_1038_s41598_024_55038_0 crossref_primary_10_1016_j_ejphar_2020_173706 crossref_primary_10_3389_fendo_2023_1139121 crossref_primary_10_3390_ph15060680 crossref_primary_10_3389_fcimb_2020_560240 crossref_primary_10_1073_pnas_2515326122 crossref_primary_10_1681_ASN_2019040337 crossref_primary_10_3390_ijms232214425 crossref_primary_10_1016_j_jid_2024_10_597 crossref_primary_10_1124_mol_119_118372 crossref_primary_10_7554_eLife_77032 crossref_primary_10_1111_jne_13418 crossref_primary_10_1021_jacs_9b08660 crossref_primary_10_3390_ijms25116219 crossref_primary_10_1124_pr_119_018044 crossref_primary_10_3389_fcell_2019_00043 crossref_primary_10_3389_fphar_2018_00128 crossref_primary_10_3390_ijms241512197 crossref_primary_10_1016_j_pharmthera_2025_108846 crossref_primary_10_1016_j_pharmthera_2024_108589 crossref_primary_10_1002_pro_70104 crossref_primary_10_3389_fendo_2021_798866 crossref_primary_10_1016_j_jsbmb_2021_105995 crossref_primary_10_1007_s10522_021_09945_8 crossref_primary_10_1152_ajprenal_00232_2025 crossref_primary_10_3389_fphar_2024_1349097 crossref_primary_10_3390_molecules28010383 crossref_primary_10_3390_cells12030377 crossref_primary_10_1002_cplu_202300386 crossref_primary_10_1016_j_cophys_2020_09_007 crossref_primary_10_1016_j_neulet_2022_136660 crossref_primary_10_1016_j_ijbiomac_2021_08_103 crossref_primary_10_1016_j_str_2023_10_010 crossref_primary_10_3390_nu15030586 crossref_primary_10_1016_j_bbamcr_2024_119798 crossref_primary_10_1038_s41596_024_01137_1 crossref_primary_10_1016_j_jpet_2025_103573 crossref_primary_10_1016_j_mce_2020_110862 crossref_primary_10_3390_ijms242316609 crossref_primary_10_1002_cbic_202100258 crossref_primary_10_3390_ijms242015250 crossref_primary_10_1016_j_bbi_2024_08_024 crossref_primary_10_1073_pnas_1810316115 crossref_primary_10_2478_jofnem_2023_0038 crossref_primary_10_1016_j_bpj_2021_11_007 crossref_primary_10_1016_j_omtn_2024_102195 crossref_primary_10_1016_j_pharmthera_2025_108877 crossref_primary_10_7554_eLife_89386 crossref_primary_10_3389_fphar_2022_847788 crossref_primary_10_1111_jnc_15314 crossref_primary_10_1021_acs_jcim_5c00202 crossref_primary_10_1038_s41467_022_29265_w crossref_primary_10_1002_1873_3468_70092 crossref_primary_10_1016_j_heliyon_2024_e29659 crossref_primary_10_3389_fendo_2023_1206063 crossref_primary_10_1039_D2CP01453J crossref_primary_10_3390_cells11040750 crossref_primary_10_1016_j_neuropharm_2023_109489 crossref_primary_10_1016_j_tips_2020_12_005 crossref_primary_10_1080_07391102_2021_1940282 crossref_primary_10_3389_fphar_2022_953903 crossref_primary_10_1039_D5RA03789A crossref_primary_10_3390_ijms20061402 crossref_primary_10_1016_j_bcp_2018_02_016 crossref_primary_10_1016_j_ijms_2022_116968 crossref_primary_10_3389_fcell_2025_1599355 crossref_primary_10_1039_D0NR01060J crossref_primary_10_1371_journal_pone_0289518 crossref_primary_10_1016_j_jbc_2021_100907 crossref_primary_10_1186_s13321_022_00654_z crossref_primary_10_1016_j_bbalip_2021_158882 crossref_primary_10_1016_j_bpj_2025_04_023 crossref_primary_10_3389_fendo_2023_1265175 crossref_primary_10_2337_db18_0796 crossref_primary_10_1016_j_heliyon_2023_e23864 crossref_primary_10_1016_j_sbi_2019_03_022 crossref_primary_10_3390_ijms22073702 crossref_primary_10_3390_cells11040660 crossref_primary_10_3390_ijms23105449 crossref_primary_10_1016_j_drudis_2023_103698 crossref_primary_10_1016_j_chom_2018_05_020 crossref_primary_10_1016_j_jmb_2025_169293 crossref_primary_10_1111_bph_15468 crossref_primary_10_3389_fendo_2021_818499 crossref_primary_10_1073_pnas_2307090121 crossref_primary_10_3389_fendo_2021_711906 crossref_primary_10_3389_pore_2021_643376 crossref_primary_10_3390_biom13101431 crossref_primary_10_1038_s41467_024_51004_6 crossref_primary_10_1074_jbc_RA117_001516 crossref_primary_10_1016_j_pharmthera_2024_108653 crossref_primary_10_1002_cmdc_202100039 crossref_primary_10_1016_j_cclet_2020_08_040 crossref_primary_10_3390_biomedicines13010046 crossref_primary_10_1016_j_xpro_2024_103383 crossref_primary_10_1016_j_semcancer_2020_04_007 crossref_primary_10_1016_j_mattod_2024_11_006 crossref_primary_10_1038_s41598_022_21321_1 crossref_primary_10_1016_j_coemr_2020_07_002 crossref_primary_10_1016_j_jmb_2025_169153 crossref_primary_10_7554_eLife_89386_2 crossref_primary_10_1074_jbc_REV120_009348 crossref_primary_10_1016_j_jbc_2025_110446 crossref_primary_10_1007_s00232_020_00167_6 crossref_primary_10_1096_fj_202000305R crossref_primary_10_1016_j_sbi_2019_03_030 crossref_primary_10_1038_s41594_021_00674_7 crossref_primary_10_1210_clinem_dgab343 crossref_primary_10_3389_fphar_2021_652335 crossref_primary_10_3389_fphar_2022_997664 crossref_primary_10_1016_j_drudis_2021_07_008 crossref_primary_10_1016_j_pharmthera_2025_108806 crossref_primary_10_3390_ph17060695 crossref_primary_10_1016_j_pharmthera_2025_108804 crossref_primary_10_3390_ijms24076187 crossref_primary_10_1111_imm_13326 crossref_primary_10_1053_j_gastro_2021_09_018 crossref_primary_10_1016_j_pharmthera_2024_108788 crossref_primary_10_1016_j_bbrc_2022_09_099 crossref_primary_10_1007_s10822_023_00497_2 crossref_primary_10_1177_1535370221993422 crossref_primary_10_1016_j_phrs_2024_107544 crossref_primary_10_3390_brainsci13070980 crossref_primary_10_3390_ph15010012 crossref_primary_10_1016_j_tibs_2024_03_006 crossref_primary_10_1016_j_carres_2025_109641 crossref_primary_10_1016_j_cellsig_2018_06_010 crossref_primary_10_1016_j_devcel_2022_07_005 crossref_primary_10_1016_j_tetlet_2020_152353 crossref_primary_10_1002_ardp_70018 crossref_primary_10_1016_j_bcp_2023_115995 crossref_primary_10_1016_j_compbiomed_2020_103660 crossref_primary_10_1021_acs_est_5c05367 crossref_primary_10_1089_nsm_2020_0015 crossref_primary_10_3390_biom13030479 crossref_primary_10_1186_s12964_020_00685_9 crossref_primary_10_3390_cells12020264 crossref_primary_10_1016_j_jbc_2024_108044 crossref_primary_10_1038_s41386_025_02202_3 crossref_primary_10_1038_s41467_022_32390_1 crossref_primary_10_1016_j_jmgm_2025_108994 crossref_primary_10_1016_j_bmcl_2023_129427 crossref_primary_10_1016_j_jmgm_2021_108107 crossref_primary_10_1146_annurev_biophys_083122_094909 crossref_primary_10_3892_ol_2022_13577 crossref_primary_10_1016_j_lfs_2019_116872 crossref_primary_10_1038_s41392_020_00435_w crossref_primary_10_1177_11779322211037769 crossref_primary_10_1021_acs_jpcb_5c04286 crossref_primary_10_3390_ijms23063303 crossref_primary_10_7554_eLife_44889 crossref_primary_10_1016_j_ceb_2018_11_001 crossref_primary_10_1021_acs_jmedchem_5c00135 crossref_primary_10_1080_19420862_2023_2213793 crossref_primary_10_3390_ijms251910470 crossref_primary_10_1007_s12649_022_01945_0 crossref_primary_10_1021_acs_jctc_5c00935 crossref_primary_10_1002_j_2040_4603_2022_tb00235_x crossref_primary_10_1038_s41557_023_01319_6 crossref_primary_10_1016_j_pharmthera_2025_108822 crossref_primary_10_1016_j_ejcb_2024_151408 crossref_primary_10_1161_CIRCULATIONAHA_119_043703 crossref_primary_10_1016_j_biochi_2022_04_006 crossref_primary_10_1016_j_tips_2024_05_010 crossref_primary_10_1038_s42003_025_08374_4 crossref_primary_10_1002_JLB_2BT1018_715RR crossref_primary_10_1016_j_copbio_2020_06_004 crossref_primary_10_1186_s12575_019_0116_y crossref_primary_10_1016_j_jmgm_2025_109150 crossref_primary_10_1038_s41467_025_59850_8 crossref_primary_10_3390_cells11162540 crossref_primary_10_1186_s12964_024_01931_0 crossref_primary_10_1016_j_tcb_2024_07_002 crossref_primary_10_1038_s41596_019_0259_y crossref_primary_10_2174_1381612825666190903153043 crossref_primary_10_3390_pharmaceutics14102218 crossref_primary_10_1186_s10020_022_00572_8 crossref_primary_10_1038_s41467_025_61057_w crossref_primary_10_1016_j_copbio_2024_103138 crossref_primary_10_1007_s00232_022_00262_w crossref_primary_10_1016_j_pharmthera_2021_107928 crossref_primary_10_3390_bios13080767 crossref_primary_10_1111_bph_14616 crossref_primary_10_1038_d41586_018_04977_6 crossref_primary_10_1016_j_pharmr_2025_100042 crossref_primary_10_1038_s41467_025_64051_4 crossref_primary_10_1073_pnas_2414738122 crossref_primary_10_3389_fmolb_2021_673053 crossref_primary_10_1016_j_phrs_2025_107597 crossref_primary_10_3390_ijms25073698 crossref_primary_10_1016_j_isci_2024_110123 crossref_primary_10_1016_j_cattod_2020_07_027 crossref_primary_10_3389_fmolb_2022_860035 crossref_primary_10_1016_j_chom_2019_07_002 crossref_primary_10_1089_ars_2021_0193 crossref_primary_10_3390_ijms241914677 crossref_primary_10_1111_bph_14960 crossref_primary_10_1016_j_biomaterials_2020_120493 crossref_primary_10_1038_s41385_022_00538_3 crossref_primary_10_1111_bph_15811 crossref_primary_10_1111_bph_15935 crossref_primary_10_1038_s41467_024_45445_2 crossref_primary_10_3389_fnagi_2019_00089 crossref_primary_10_1016_j_cell_2022_03_042 crossref_primary_10_1016_j_cellsig_2018_11_003 crossref_primary_10_3389_fcell_2020_611269 crossref_primary_10_1073_pnas_2208077119 crossref_primary_10_1515_hsz_2019_0292 crossref_primary_10_1089_scd_2022_0201 crossref_primary_10_3390_ijms25158339 crossref_primary_10_1016_j_ceb_2019_01_003 crossref_primary_10_1016_j_chom_2019_07_018 crossref_primary_10_1016_j_jbc_2025_110571 crossref_primary_10_3389_fendo_2023_1301017 crossref_primary_10_1021_acs_jpclett_4c02875 crossref_primary_10_4103_bbrj_bbrj_104_23 crossref_primary_10_3390_molecules26051465 crossref_primary_10_1016_j_tem_2020_11_008 crossref_primary_10_1002_tcr_202300113 crossref_primary_10_1016_j_csbj_2022_11_042 crossref_primary_10_3389_fnins_2024_1357873 crossref_primary_10_1111_febs_15783 crossref_primary_10_1038_s42003_020_0867_7 crossref_primary_10_3390_cells11081317 crossref_primary_10_2174_0929867328666210525141728 crossref_primary_10_1007_s12079_019_00527_5 crossref_primary_10_1016_j_bbcan_2022_188756 crossref_primary_10_1007_s00018_022_04221_5 crossref_primary_10_1073_pnas_2203702119 crossref_primary_10_1002_prp2_556 crossref_primary_10_1016_j_conb_2022_102601 crossref_primary_10_1038_s41598_023_49799_3 crossref_primary_10_1002_pro_4866 crossref_primary_10_3390_pharmaceutics12111079 crossref_primary_10_1016_j_ibmb_2020_103359 crossref_primary_10_1016_j_neuropharm_2018_12_022 crossref_primary_10_1002_chem_202000924 crossref_primary_10_1016_j_chemphyslip_2020_104955 crossref_primary_10_1111_bph_15710 crossref_primary_10_7554_eLife_96513 crossref_primary_10_3389_fphar_2024_1372109 crossref_primary_10_1016_j_bcp_2022_115028 crossref_primary_10_1126_science_abl4732 crossref_primary_10_1016_j_pestbp_2019_07_001 crossref_primary_10_1016_j_str_2025_07_012 crossref_primary_10_1515_hsz_2021_0409 crossref_primary_10_1002_chem_202401393 crossref_primary_10_1016_j_str_2019_10_004 crossref_primary_10_1177_1934578X251348390 crossref_primary_10_3390_ijms23031420 crossref_primary_10_3390_ijms232314778 crossref_primary_10_1016_j_pharmr_2025_100056 crossref_primary_10_3389_fonc_2022_847543 crossref_primary_10_1002_jat_3952 crossref_primary_10_1016_j_neuropharm_2018_11_010 crossref_primary_10_1074_jbc_H118_002879 crossref_primary_10_1111_andr_70018 crossref_primary_10_1016_j_bbih_2023_100671 crossref_primary_10_1016_j_isci_2023_107841 crossref_primary_10_1042_EBC20220169 crossref_primary_10_1016_j_smim_2022_101603 crossref_primary_10_1002_1873_3468_70081 crossref_primary_10_1016_j_tips_2020_01_009 crossref_primary_10_1038_s41598_023_47698_1 crossref_primary_10_3390_ijms221910784 crossref_primary_10_1074_jbc_RA119_009253 crossref_primary_10_1038_s41392_024_01803_6 crossref_primary_10_1002_pro_70090 crossref_primary_10_1124_molpharm_123_000722 crossref_primary_10_1124_mol_119_116954 crossref_primary_10_3390_cells11040703 crossref_primary_10_1161_CIRCRESAHA_123_323752 crossref_primary_10_1111_jnc_15979 crossref_primary_10_1016_j_pharmthera_2021_107842 crossref_primary_10_1002_ijch_202300152 crossref_primary_10_1111_febs_70145 crossref_primary_10_1007_s00232_019_00091_4 crossref_primary_10_1038_s41541_024_00979_w crossref_primary_10_1073_pnas_2304897121 crossref_primary_10_3390_cells13151244 crossref_primary_10_1007_s12035_020_02085_z crossref_primary_10_1371_journal_ppat_1008059 crossref_primary_10_1124_pharmrev_121_000524 crossref_primary_10_1042_EBC20220173 crossref_primary_10_3390_biomedicines12061320 crossref_primary_10_1016_S1474_4422_24_00032_2 crossref_primary_10_1016_j_plefa_2025_102680 crossref_primary_10_7554_eLife_65620 crossref_primary_10_1016_j_pharmthera_2021_107836 crossref_primary_10_1038_s41570_020_0201_4 crossref_primary_10_1371_journal_pone_0230872 crossref_primary_10_1002_pro_3509 crossref_primary_10_1016_j_tibs_2020_07_008 crossref_primary_10_1016_j_cell_2020_02_047 crossref_primary_10_1038_s41538_020_00075_y crossref_primary_10_1016_j_arcmed_2022_06_008 crossref_primary_10_1016_j_jbc_2024_105756 crossref_primary_10_3389_fcell_2021_611443 crossref_primary_10_1182_bloodadvances_2020002683 crossref_primary_10_1038_s41401_024_01385_7 crossref_primary_10_3390_ijms232113598 crossref_primary_10_1177_0022034520915877 crossref_primary_10_1016_j_csbj_2023_08_032 crossref_primary_10_1038_s41467_024_46177_z crossref_primary_10_1080_17460441_2023_2216014 crossref_primary_10_1016_j_csbj_2023_08_034 crossref_primary_10_3389_fphar_2023_1158091 crossref_primary_10_1093_bib_bbae105 crossref_primary_10_1016_j_neuropharm_2022_109408 crossref_primary_10_1124_molpharm_122_000580 crossref_primary_10_3390_ijms20081970 crossref_primary_10_1016_j_neurobiolaging_2019_03_008 crossref_primary_10_14814_phy2_15212 crossref_primary_10_1038_s41380_019_0512_3 crossref_primary_10_1007_s12272_020_01263_w crossref_primary_10_1016_j_ejphar_2022_175018 crossref_primary_10_2174_0929867326666190429153247 crossref_primary_10_1016_j_tips_2023_05_001 crossref_primary_10_1111_febs_15344 crossref_primary_10_1371_journal_pone_0259129 crossref_primary_10_1016_j_cellsig_2022_110333 crossref_primary_10_1134_S0006297921020012 crossref_primary_10_1016_j_jbc_2024_107926 crossref_primary_10_1016_j_trsl_2021_03_008 crossref_primary_10_1038_s41580_018_0049_3 crossref_primary_10_1016_j_apsoil_2025_106043 crossref_primary_10_3389_fnins_2020_574499 crossref_primary_10_1042_BST20210650 crossref_primary_10_1124_molpharm_124_000949 crossref_primary_10_3390_cells9020506 crossref_primary_10_3390_ma14154151 crossref_primary_10_1073_pnas_2021596118 crossref_primary_10_1038_s41587_023_01987_2 crossref_primary_10_1038_s41573_024_00958_9 crossref_primary_10_1016_j_phrs_2024_107395 crossref_primary_10_1039_D1NR02419A crossref_primary_10_3390_ijms24054667 crossref_primary_10_1016_j_pharmthera_2019_02_012 crossref_primary_10_1371_journal_pone_0320114 crossref_primary_10_1016_j_str_2024_04_018 crossref_primary_10_1038_s41467_025_55901_2 crossref_primary_10_1038_s41467_021_26882_9 crossref_primary_10_3390_molecules30051047 crossref_primary_10_7554_eLife_65962 crossref_primary_10_1007_s11033_024_09876_w crossref_primary_10_7554_eLife_60155 crossref_primary_10_1007_s10822_019_00201_3 crossref_primary_10_1124_pharmrev_121_000423 crossref_primary_10_1186_s12915_024_02017_6 crossref_primary_10_1016_j_drudis_2018_04_004 crossref_primary_10_1016_j_jmb_2019_02_030 crossref_primary_10_1080_17460441_2023_2275640 crossref_primary_10_1016_j_bcp_2020_113889 crossref_primary_10_1016_j_molmet_2019_09_015 crossref_primary_10_1124_molpharm_124_000939 |
| ContentType | Journal Article |
| Copyright | Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics. |
| Copyright_xml | – notice: Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1124/mol.117.111062 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1521-0111 |
| ExternalDocumentID | 29298813 |
| Genre | Research Support, U.S. Gov't, Non-P.H.S Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIA NIH HHS grantid: R21 AG052914 – fundername: NIA NIH HHS grantid: R21 AG053568 |
| GroupedDBID | --- -~X .55 .GJ 0R~ 123 18M 2WC 34G 39C 4.4 53G 5RE 5VS AAXUO ABCQX ABJNI ABSQV ACGFO ACGFS ADBBV ADCOW AENEX AERNN AFFNX AFOSN ALMA_UNASSIGNED_HOLDINGS AYCSE BAWUL BTFSW CGR CS3 CUY CVF DIK E3Z EBS ECM EIF EJD F5P F9R FDB GX1 H13 HZ~ IH2 INIJC K-O KQ8 L7B LSO M41 MVM N9A NPM O9- OK1 P2P R.V R0Z RHI ROL RPT TR2 UQL W8F WOQ X7M XOL YBU YHG ZGI ZXP 7X8 AALRI |
| ID | FETCH-LOGICAL-c439t-b27a033dd4e72f9504cdc026734352db2d88eb93e5514987ab3f9f5438cb2c022 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 904 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000425542500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1521-0111 |
| IngestDate | Fri Sep 05 13:03:08 EDT 2025 Thu Apr 03 07:05:12 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c439t-b27a033dd4e72f9504cdc026734352db2d88eb93e5514987ab3f9f5438cb2c022 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://molpharm.aspetjournals.org/content/molpharm/93/4/251.full.pdf |
| PMID | 29298813 |
| PQID | 1984751466 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1984751466 pubmed_primary_29298813 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-04-00 20180401 |
| PublicationDateYYYYMMDD | 2018-04-01 |
| PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-00 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Molecular pharmacology |
| PublicationTitleAlternate | Mol Pharmacol |
| PublicationYear | 2018 |
| SSID | ssj0014580 |
| Score | 2.701883 |
| SecondaryResourceType | review_article |
| Snippet | Estimates vary regarding the number of G protein-coupled receptors (GPCRs), the largest family of membrane receptors that are targeted by approved drugs, and... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 251 |
| SubjectTerms | Animals Databases, Factual - trends Drug Delivery Systems - methods Drug Delivery Systems - trends Humans Pharmaceutical Preparations - administration & dosage Pharmaceutical Preparations - metabolism Receptors, G-Protein-Coupled - metabolism |
| Title | G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs? |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29298813 https://www.proquest.com/docview/1984751466 |
| Volume | 93 |
| WOSCitedRecordID | wos000425542500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAMrDwfpSXjISYarW1ncZmqRBQOkCVoUjdIsd2UKWSlKYt6r_nnAQyISGxZIguUuRc7r7znb8PoesYkoqK45i0qdaEG2GIpFClKCY92zYGnCqnzH_2BwMxGsmg3HDLyrHK75iYB2qTardH3oTimPuQ3Tud7vSDONUo110tJTTWUY0BlHFe7Y-qLgL3cuU0l6KI01QvSRshpTXf04nrV7qI0XJKOb_ByzzN9Hb--4K7aLsEmPiu8Ig9tGaTfXQTFAzVqwYeVgeusga-wUHFXb06QOETDhxzwzgh9-liOrEGA7C0U6fJg1WGh_ngeIYB6uI7R0e-BIuH2eItu8X99BO_QGz5MVKJqW7mRt1D9Np7HN73SanBQDRAlTmJqK9ajBnDrU9j6bW4NtqpVjHAWdRE1AhhI8msQ15S-CpisYw9zoSOKBjSI7SRpIk9QZgx2TKSaeFbn3vKKCiO24DHIh5FrKN4HV19L2wIPu4aFyqx6SILq6Wto-Pi64TTgowjpIDvhGiz0z88fYa2wDVFMXhzjmox_OH2Am3q5XyczS5z54HrIHj5AlUzzfM |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=G+Protein-Coupled+Receptors+as+Targets+for+Approved+Drugs%3A+How+Many+Targets+and+How+Many+Drugs%3F&rft.jtitle=Molecular+pharmacology&rft.au=Sriram%2C+Krishna&rft.au=Insel%2C+Paul+A&rft.date=2018-04-01&rft.issn=1521-0111&rft.eissn=1521-0111&rft.volume=93&rft.issue=4&rft.spage=251&rft_id=info:doi/10.1124%2Fmol.117.111062&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1521-0111&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1521-0111&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1521-0111&client=summon |